Vascular thrombosis |
≥1 clinical episode of arterial, venous, or small vessel thrombosis.
Thrombosis must be objectively confirmed.
For histopathological confirmation, thrombosis must be present without inflammation of the vessel wall.
|
Pregnancy morbidity |
≥1 unexplained death of a morphologically normal fetus ≥10 weeks of gestation.
≥1 premature delivery of a morphologically normal fetus <34 weeks of gestation because of.
Severe preeclampsia or eclampsia defined according to standard definition.
Recognized features of placental insufficiency.
≥3 unexplained consecutive miscarriages < 10 weeks of gestation, with maternal and paternal factors (anatomic, hormonal, or chromosomal abnormalities) excluded.
|
Laboratory criteria |
Presence of aPL, on two or more occasions at least 12 weeks apart and no more than 5 years prior to clinical manifestations, as demonstrated by ≥1 of the following.
LA.
Medium to high-titer (>40 GPL or MPL, or >99th percentile) aCL IgG or IgM.
Anti-β2 glycoprotein-I (anti-β2GPI) IgG or IgM > 99th percentile.
|